Literature DB >> 17914205

Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration.

Jenet J Chieh1, Sharon Fekrat.   

Abstract

We report the development of a large subretinal hemorrhage 4 weeks after intravitreal bevacizumab in an 84-year-old male with 20/70 visual acuity caused by occult choroidal neovascularization from neovascular age-related macular degeneration in one eye that was treated with 1.25 mg of intravitreal bevacizumab.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17914205     DOI： 10.1007/bf02697326

Source DB:  PubMed          Journal:  Ann Ophthalmol (Skokie)        ISSN： 1530-4086


  5 in total

1.  Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration.

Authors:  R Prince Davis; Amy C Schefler; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2010-07-30

Review 2.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology.

Authors:  Jonathan A Micieli; Andrew Micieli
Journal:  Mcgill J Med       Date:  2011-06

4.  Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy.

Authors:  Aditya Kelkar; Poonam Gandhi; Winfried Amoaku; Jai Kelkar; Shreekant Kelkar; Priyanka Raut; Rachana Shah
Journal:  Case Rep Ophthalmol       Date:  2014-07-11

5.  Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration.

Authors:  Mehdi Modarreszadeh; Masood Naseripour; Khalil Ghasemi-Falavarjani; Aminollah Nikeghbali; Masih Hashemi; Mohammad-Mehdi Parvaresh
Journal:  J Ophthalmic Vis Res       Date:  2008-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.